Sexual Health After 45: Beyond the Aging Label
On October 12, 2026, Hindustan Times published “Why men should pay attention to sexual and reproductive health,” written by urologist Prof. (Dr.) Rajeev Sood of Pacific OneHealth Hospitals.
Behind the evidence
The feature presents a clinical argument about sexual and reproductive health. It is not a newly published treatment trial. Its main numerical example comes from a study of 175 Indian men undergoing coronary angiography.
That description establishes the participants’ sex and country and identifies their clinical setting. The available account does not provide their age distribution, recruitment methods or study duration. It therefore offers no trial timeline or detailed method for readers to assess.
A separate source supplies the clinical framework: the European Association of Urology (EAU) guideline on erectile dysfunction. Its recommendations cover medical history, physical examination and selected laboratory checks. These recommendations are distinct from the findings reported in the Hindustan Times feature.
Keeping that distinction clear matters. A study finding describes what was observed in a particular group. A guideline explains how clinicians can approach a health concern. Neither should be presented as evidence that a treatment tested in this feature improved men’s health.
Reported findings
The Hindustan Times feature reports two outcomes from the angiography study:
- Erectile dysfunction was reported in 70% of the 175 participants.
- Men with erectile dysfunction had a higher incidence of multivessel coronary artery disease. The feature does not provide a numerical size for that difference.
These are the study outcomes reported by the feature. Its wider discussion addresses symptom associations and the case for assessment across several areas of health.
Heart health links
The feature says erectile dysfunction, or ED, may be associated with diabetes, hypertension, obesity and abnormal cholesterol. It also identifies psychological factors and aging as possible contributors.
The EAU guideline provides a separate reason to take the cardiovascular connection seriously. It characterizes ED as a cardiovascular risk signal. It also says that more severe and longer-standing ED is associated with greater cardiovascular risk.
This explains why a clinical conversation about ED may extend beyond sexual function. The assessment described by the guideline includes factors that also belong in a broader cardiovascular and metabolic review. For related context, the discussion of sexual function within overall health addresses that wider perspective.
Hormones need context
The Hindustan Times feature lists reduced libido, fatigue, changes in sexual function and loss of muscle strength as possible symptoms associated with low testosterone. It also states that these concerns can have other causes and calls for assessment before treatment.
For men concerned about strength or energy after 45, this is a useful distinction. Noticing a change is different from identifying its cause. A symptom list is a starting point for a medical conversation rather than a label to apply to oneself.
The EAU guideline includes early-morning total testosterone measured fasting as part of an ED evaluation. It says bioavailable or calculated free testosterone may be considered when needed to corroborate the result. This places hormone testing within an assessment rather than treating low testosterone as the default explanation for sexual changes.
A broader examination
The EAU guideline recommends a detailed medical and sexual history. It also describes examination of relevant urinary and reproductive systems, hormonal systems, blood vessels and the nervous system.
The Hindustan Times feature adds a whole-person framing that includes medication-related and psychological factors. Together these sources support a conversation that is wider than a request for a testosterone test. Sexual symptoms sit within a person’s medical history rather than outside it.
For the reader, the useful point is the scope of the review. Symptoms, medications and psychological concerns are relevant topics to bring into a clinician-led discussion. They are not competing explanations that a man has to sort out on his own before seeking care.
Metabolic checks
The EAU guideline recommends checking blood pressure and heart rate if they have not been assessed in the previous three to six months. It also recommends fasting glucose or HbA1c and a lipid profile if those measures have not been assessed during the previous 12 months.
BMI or waist circumference is also included when assessing comorbid conditions such as metabolic syndrome. These recommendations show why an ED evaluation may include measurements that do not appear directly sexual.
For men interested in understanding common metabolic markers, this is a connection between sexual symptoms and a wider health review. The guideline’s timing and clinical context belong with the recommendation. The list should not become a fixed testing panel that every reader arranges independently.
Beyond erectile function
The Hindustan Times feature also discusses infertility and urinary symptoms. Its broader argument is that men’s sexual and reproductive health should not be reduced to prostate concerns alone.
That framing gives urinary changes a place in the same clinical conversation. Men do not need to treat a troubling sexual concern and a urinary concern as unrelated subjects that must be raised at separate times. The feature’s message is to bring persistent or troubling changes to a medical practitioner rather than dismiss them automatically by age.
Evidence limits
The publication context deserves attention. The Hindustan Times page identifies the feature as part of its paid Consumer Connect initiative. It says the material was independently created by the brand and is not the newspaper’s editorial content.
That disclosure makes this commercial health communication rather than an independent medical investigation. The author’s role at Pacific OneHealth Hospitals is also relevant institutional context. The EAU guideline offers a separate basis for the assessment recommendations discussed here.
The angiography finding has a specific boundary. Men undergoing that procedure are a selected clinical group rather than a sample representing men overall. The reported 70% is not a population estimate, and the feature explicitly says ED does not mean every affected man has heart disease.
The testosterone material also stops short of a complete diagnostic or treatment framework. The feature provides no diagnostic cutoff or treatment criteria. The EAU testing recommendations supplied here do not establish a complete protocol for diagnosing or treating testosterone deficiency.
Finally, the EAU guideline says an evaluation may identify comorbid conditions and reversible risk factors without finding the exact cause of ED in every patient. The value of assessment is broader than receiving one simple explanation.
The practical meaning
For men after 45, the useful response is neither dismissal nor alarm. Persistent or troubling sexual and urinary changes deserve a conversation with a qualified clinician. The feature’s advice to consult a registered medical practitioner fits that approach.
That conversation can cover the symptoms themselves alongside medical and sexual history, medications and psychological factors. A clinician can then assess whether cardiovascular, metabolic or hormonal factors merit review. Personal testing and treatment decisions belong in that setting.
The practical question is not simply “Is this normal aging?” It is “What assessment is appropriate for this change?” That question leaves room for the range of contributors described by the sources without assuming a hormone deficiency or cardiovascular diagnosis.
What this changes: The feature does not alter current best practice; it reinforces guideline-based assessment rather than dismissal by age or treatment based on symptoms alone.
How Everfitguys helps
Changes in muscle strength and sexual function call for clear evidence, and Everfitguys explains hormonal health research for men 45 and older. Confusion about testosterone claims can obscure the difference between symptoms and established findings; the publication helps readers understand which healthy aging claims have research support.
Sources
Stay sharp
Get stories
The best writing on craft and life, delivered once a week. No noise, just the good stuff.
